We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

MicroCutter in Surgical Stapling - European Trial I (MET1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01476761
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : August 9, 2013
Information provided by (Responsible Party):
Cardica, Inc

Brief Summary:
The purpose of this study is to evaluate safety of the Microcutter stapling /cutting device in patients requiring the transection, resection or anastomosis of gastrointestinal tissue in a post-market approval study.

Condition or disease Intervention/treatment Phase
Thoracic Device: Microcutter XPRESS and Microcutter XCHANGE Phase 4

Detailed Description:
A prospective, open label, multi-center non-inferiority safety study with an all-comers enrollment of patients requiring surgical stapling of the stomach and/or intestine according to the labeled indications contained in the approved labeling. Up to 178 subjects consented for a 1-month clinical follow-up evaluation will be enrolled. Primary endpoint is to statistical non-inferiority of composite major adverse event rate (composite of infection (non-dermal), dehiscence, bleeding, and strictures) in study patients when compared to composite major adverse event rate (composite of infection (non-dermal), dehiscence, bleeding, and strictures) as derived from a comprehensive analysis of the medical literature. The comparison will be performed for cumulative events up to 30 days postoperatively.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 160 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Cardica MicroCutter in Surgical Stapling: A Prospective, Open-label, Multi-center Study
Study Start Date : November 2011
Primary Completion Date : June 2013
Study Completion Date : July 2013

Arm Intervention/treatment
Active Comparator: MicroCutter Stapling Device
Patients undergoing surgical treatment with the MicroCutter Stapling Device
Device: Microcutter XPRESS and Microcutter XCHANGE
Surgical stapling devices
Other Names:
  • MicroCutter XPRESS30
  • MicroCutter XPRESS45
  • MicroCutter XCHANGE30

Primary Outcome Measures :
  1. Composite adverse event rate [ Time Frame: up to 30 days postoperatively ]
    Composite event rate is a compilation of the following stapling related adverse event rates: bleeding, leakage, stricture and infection

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

- All patients requiring surgical treatment where the use of a surgical stapler is anticipated

Exclusion Criteria:

- None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01476761

DRK-Krankenahus Clementinenhaus
Hannover, Germany
Sponsors and Collaborators
Cardica, Inc
Principal Investigator: Andreas Kithe, M.D. DRK-Krankenhaus Clementinenhaud, Hannover

Additional Information:
Responsible Party: Cardica, Inc
ClinicalTrials.gov Identifier: NCT01476761     History of Changes
Other Study ID Numbers: CP 2011-01
First Posted: November 22, 2011    Key Record Dates
Last Update Posted: August 9, 2013
Last Verified: August 2013

Keywords provided by Cardica, Inc:
Surgical tissue resection
Tissue dissection
Tissue transection
Anastomosis of gastrointestina tissue